Taxotere® Chemotherapy Drug
Hair Loss


Relion Group’s attorneys are currently accepting cases for Taxotere® hair loss lawsuit.

Taxotere® lawsuits allege that chemo-drug manufacturer Sanofi-Aventis U.S. LLC knowingly exposed breast cancer patients to an unnecessary risk of permanent alopecia (permanent hair loss) without efficacy of chemo treatment itself.

Financial compensation may be available through a Taxotere lawsuit for women who were diagnosed with breast cancer and received chemotherapy treatment and then suffered from permanent hair loss (alopecia).

Taxotere® lawsuits blame the chemo drug manufacturer in following:

  • Taxotere Chemo Drug Hair LossNegligence
  • Intentional Infliction of Emotional Distress
  • Failure to Warn
  • Fraudulent Misrepresentation
  • Design & Manufacturing Defects
  • Violation of Consumer Protection Laws

If you or your family member was diagnosed with breast cancer and suffered from permanent hair loss AKA “alopecia” after receiving the chemotherapy drug Taxotere®, you may be entitled to significant financial compensation.

We will connect you with an experienced Taxotere attorney, who specializes in dealing with such cases. Our attorneys dedicated to the Taxotere lawsuit provide free consultations.

If you meet the requirements for Taxotere® hair loss lawsuit, you may be eligible to receive financial compensation, upon settlement of the lawsuit.

Start Now